Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637452 · ClinicalTrials.gov registry record
Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability
A clinical trial of Tobacco Use, sponsored by University of Oklahoma.
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT03637452: Completed study of Tobacco Use, sponsored by University of Oklahoma.
NCT03637452 is a study of Tobacco Use that has completed, run by University of Oklahoma. The registered enrollment target is 19 participants, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637452, a study of Tobacco Use, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of the current research is to understand purchasing and product choice behaviors of tobacco/nicotine users if banning the sale of fully nicotinized cigarettes were to go into effect. A sample of up to 30 current cigarette users (n=15) and dual e-cigarette and combustible cigarette users (n=15) who are willing to try an alternative nicotine-delivery device will be recruited. They will complete the screening visit, visit 1 and 2 preceded by 12 hours of nicotine/tobacco abstinent.
Primary Outcome
Participants will complete one standardized puffing bout (10 puffs) with each of the three electronic cigarettes and their usual brand cigarette. Serum nicotine will be measured throughout each standardized puffing bout. Greater levels of serum nicotine will be indicative of greater nicotine delivery.
Conditions Studied
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center Tobacco Research Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-12 |
| Est. Completion | 2019-05-23 |
What the finished NCT03637452 record still lists
NCT03637452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 379-participant average among 76 other Tobacco Use trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 0 interventions.
NCT03637452 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03637452 about?
NCT03637452 is a clinical study titled "Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability". The overall aim of the current research is to understand purchasing and product choice behaviors of tobacco/nicotine users if banning the sale of fully nicotinized cigarettes were to go into effect. A sample of up to 30 current cigarette users (n=15) and dual e-cigarette and combustible cigarette us...
What is the current status of trial NCT03637452?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2018-11-12. Estimated completion is 2019-05-23.
What conditions does trial NCT03637452 study?
This clinical trial studies the following conditions: Tobacco Use.
Who is sponsoring clinical trial NCT03637452?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03637452 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03637452's enrollment target sits among peer trials
19 73rd of 76 higher than 4 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
RECRUITING · Phase 2
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI